These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4318814)

  • 21. Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1971 Jul; 15(4):293-300. PubMed ID: 4398080
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of indirect immunofluorescence and radioimmunoassay for detecting antibody to varicella-zoster virus.
    Campbell-Benzie A; Heath RB; Ridehalgh MK; Cradock-Watson JE
    J Virol Methods; 1983 Mar; 6(3):135-40. PubMed ID: 6306029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic relationship of varicella-zoster and herpes simplex.
    Ross CA; Subak Sharpe JH; Ferry P
    Lancet; 1965 Oct; 2(7415):708-11. PubMed ID: 4157772
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster].
    Trivello R; Peserico A; Moschen ME; Romano M
    Ann Sclavo; 1977; 19(6):1133-43. PubMed ID: 218503
    [No Abstract]   [Full Text] [Related]  

  • 25. The serological relationship of varicella-zoster virus to other primate herpesviruses.
    Harbour DA; Caunt AE
    J Gen Virol; 1979 Nov; 45(2):469-77. PubMed ID: 232132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the specificity of the complement fixation test in cytomegalovirus infections. With special reference to possible cross-reactions with other herpesvirus antigens.
    Andersen HK; Godtfredsen A; Spencer ES
    Scand J Infect Dis; 1971; 3(3):183-7. PubMed ID: 4331836
    [No Abstract]   [Full Text] [Related]  

  • 27. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of precipitins to varicella-zoster virus in different age groups.
    Trlifajová J; Sourek J
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):366-9. PubMed ID: 4342923
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody levels to parainfluenza, herpes simplex, varicella-zoster, cytomegalo virus, and measles virus in patients with connective tissue diseases.
    Kalliomäki JL; Halonen P
    Ann Rheum Dis; 1972 May; 31(3):192-5. PubMed ID: 4338106
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement-fixing antigens produced by varicella-zoster virus in tissue culture.
    Martin ML; Palmer EL
    Appl Microbiol; 1973 Sep; 26(3):410-6. PubMed ID: 4356464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple mathematical deductions in the seroepidemiology of viral infections. I. Herpesvirus group (herpesvirus hominis, varicella-zoster virus, cytomegalovris, Epstein-Barr-Virus).
    Doerr HW; Lehmair H; Schmitz H; Kampa D; Luthardt T
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):149-64. PubMed ID: 196453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization tests with varicella-zoster virus.
    Caunt AE; Shaw DG
    J Hyg (Lond); 1969 Jun; 67(2):343-52. PubMed ID: 4183291
    [No Abstract]   [Full Text] [Related]  

  • 34. Preparation of concentrated intracellular precipitating antigens of varicella-zoster and herpes simplex viruses and results obtained with them in the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1970 Jan; 14(1):25-34. PubMed ID: 4392074
    [No Abstract]   [Full Text] [Related]  

  • 35. Zoster, reinfection or activation of latent virus? Observations on the antibody response.
    Miller LH; Brunell PA
    Am J Med; 1970 Oct; 49(4):480-3. PubMed ID: 4320119
    [No Abstract]   [Full Text] [Related]  

  • 36. [Viral profile of multiple sclerosis. Study of virus complement fixing antibodies].
    Daniel P
    Nouv Presse Med; 1972 Jul; 1(29):1939-42. PubMed ID: 4340874
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRUDE TISSUE CULTURE ANTIGEN FOR DETERMINATION OF VARICELLA-ZOSTER COMPLEMENT FIXING ANTIBODY.
    BRUNELL PA; CASEY HL
    Public Health Rep (1896); 1964 Sep; 79(9):839-42. PubMed ID: 14213793
    [No Abstract]   [Full Text] [Related]  

  • 39. Indirect haemagglutination reaction (LH)-the method of choice for the detection of anamnestic antibodies to varicella - zoster (VZ) virus.
    Trlifajová J; Ryba M; Jelĭnek J
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):101-6. PubMed ID: 177705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of anti-varicella-zoster virus antibodies in blood donors by automated passive haemagglutination.
    Chung A; Naylor DH
    Vox Sang; 1981; 41(4):245-8. PubMed ID: 6278772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.